McKean A, Monasterio E. Indications of atypical antipsychotics in the elderly. Expert Rev Clin Pharmacol. 2015;8(1):5–7.
University SECaB. Patterns of medication use in the United States 2006, A report from the Slone survey. 2006. [cited 2021 April]; Available from https://www.bu.edu/slone/files/2012/11/SloneSurveyReport2006.pdf
Gustafsson M, Karlsson S, Lövheim H. Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacol Toxicol. 2013;14(1):1–8.
Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta analysis. Eur J Clin Pharmacol. 2017;73(6):759–70.
Article CAS PubMed Google Scholar
Somers A, Robays H, Vander Stichele R, et al. Contribution of drug related problems to hospital admission in the elderly. J Nutr, Health Aging. 2010;14:477–82.
Article CAS PubMed Google Scholar
Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31(4):199–205.
Article CAS PubMed Google Scholar
Rogers S, Wilson D, Wan S, et al. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging. 2009;26(11):951–61.
The American Geriatrics Society Beers Criteria Update Expert P. American geriatrics society 2019 updated AGS Beers criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019; 67(4):674–94.
O’Mahony D, Cherubini A, Guiteras AR, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625–32.
Article PubMed PubMed Central Google Scholar
Park S, Kim AJ, Ah YM, et al. Prevalence and predictors of medication-related emergency department visit in older adults: a multicenter study linking national claim database and hospital medical records. Front Pharmacol. 2022;13:1009485.
Article PubMed PubMed Central Google Scholar
Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8(2):151–7.
Article CAS PubMed Google Scholar
Doherty AS, Shahid F, Moriarty F, et al. Prescribing cascades in community-dwelling adults: a systematic review. Pharmacol Res Perspect. 2022;10(5):e01008.
Article PubMed PubMed Central Google Scholar
Renom-Guiteras A, Thurmann PA, Miralles R, et al. Potentially inappropriate medication among people with dementia in eight European countries. Age Ageing. 2018;47(1):68–74.
Bargagli AM, Cascini S, Agabiti N, et al. Determinants Of antipsychotic drugs prescription among community-living older adults with dementia: a population-based study using health information systems in the Lazio region. Italy Clin Interv Aging. 2019;14:2071–83.
Article CAS PubMed Google Scholar
Stock KJ, Hogan DB, Lapane K, et al. Antipsychotic use and hospitalization among older assisted living residents: does risk vary by frailty status? Am J Geriatr Psychiatry. 2017;25(7):779–90.
Rikala M, Korhonen MJ, Sulkava R, et al. Psychotropic drug use in community-dwelling elderly people-characteristics of persistent and incident users. Eur J Clin Pharmacol. 2011;67(7):731–9.
Sonnerstam E, Gustafsson M, Lovheim H, et al. Potentially inappropriate medications pre-and post-diagnosis of major neurocognitive disorders among older people in Sweden: a register-based, 6-year longitudinal study. Drugs Aging. 2022;39(7):573–85.
Article PubMed PubMed Central Google Scholar
Oh S, Byeon SJ, Chung SJ. Characteristics of adverse reactions among antipsychotic drugs using the Korean adverse event reporting system database from 2010 to 2019. J Psychopharmacol. 2022;36(9):1041–50.
Adam L, Moutzouri E, Baumgartner C, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769.
PubMed PubMed Central Google Scholar
Blum MR, Sallevelt B, Spinewine A, et al. Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374:n1585.
Article PubMed PubMed Central Google Scholar
Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J. 1965;14:61–5.
WHO. Defined daily dose (DDD)-definition and general considerations. [cited 2021 April]; Available from: https://www.who.int/tools/atc-ddd-toolkit/about-ddd.
World Health Organization, The use of the WHO-UMC system for standardised case causality assessment. 2013. [cited 2021 April]; Available from: https://www.who.int/publications/m/item/WHO-causality-assessment
Thevelin S, Spinewine A, Beuscart JB, et al. Development of a standardized chart review method to identify drug-related hospital admissions in older people. Br J Clin Pharmacol. 2018;84(11):2600–14.
Article PubMed PubMed Central Google Scholar
Rhee Y, Csernansky JG, Emanuel LL, et al. Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia. J Am Geriatr Soc. 2011;59(11):2100–7.
Article PubMed PubMed Central Google Scholar
Sakuma M, Kanemoto Y, Furuse A, et al. Frequency and severity of adverse drug events by medication classes: the JADE study. J Patient Saf. 2020;16(1):30–5.
Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962–8.
Lin CW, Wen YW, Chen LK, et al. Potentially high-risk medication categories and unplanned hospitalizations: a case-time-control study. Sci Rep. 2017;7:41035.
Article CAS PubMed PubMed Central Google Scholar
Copeland LA, Zeber JE, Valenstein M, et al. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry. 2003;160(10):1817–22.
Church MK, Church DS. Pharmacology of antihistamines. Indian J Dermatol. 2013;58(3):219–24.
Article MathSciNet PubMed PubMed Central Google Scholar
Sica DA. Alpha1-adrenergic blockers: current usage considerations. J Clin Hypertens (Greenwich). 2005;7(12):757–62.
Article CAS PubMed Google Scholar
Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15–28.
Article CAS PubMed Google Scholar
Hálfdánarson Ó, Zoëga H, Aagaard L, et al. International trends in antipsychotic use: a study in 16 countries, 2005–2014. Eur Neuropsychopharmacol. 2017;27(10):1064–76.
Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121–6.
Article CAS PubMed PubMed Central Google Scholar
Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging. 1999;14(2):141–52.
Article CAS PubMed Google Scholar
Ayalew MB, Tegegn HG, Abdela OA. Drug related hospital admissions; a systematic review of the recent literatures. Bull Emerg Trauma. 2019;7(4):339–46.
Article PubMed PubMed Central Google Scholar
Rothschild JM, Mann K, Keohane CA, et al. Medication safety in a psychiatric hospital. Gen Hosp Psychiatry. 2007;29(2):156–62.
O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
Anderson SL, Vande Griend JP. Quetiapine for insomnia: a review of the literature. Am J Health-Syst Pharm. 2014;71(5):394–402.
Article CAS PubMed Google Scholar
Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
Article PubMed PubMed Central Google Scholar
Gareri P, Segura-Garcia C, Manfredi VG, et al. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363–73.
PubMed PubMed Central Google Scholar
Howe J, Lindsey L. The role of pharmacists in supporting service users to optimise antipsychotic medication. Int J Clin Pharm. 2023;45(5):1293–8.
留言 (0)